Sanofi India Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: SANOFI BSE: 500674

₹3057.00

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #52 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Sanofi India Limited (this stock)	7,040	21.7	43.6%	-35.0%	4.02%	98	27	46

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (Dec. 31, 2025). EBITDA = PBT + interest + depreciation.

Enterprise value

₹6,778 Cr

EV / EBITDA

14.3x

EV / Sales

3.75x

Market cap / Sales

3.90x

Earnings yield

4.60%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 444 Cr, up 7.0% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 84 Cr, up 20.1% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	438	112	84	₹36.2600
March 31, 2026	472	138	103	₹44.5500
Dec. 31, 2025	420	83	62	₹26.7900
Sept. 30, 2025	475	102	76	₹32.9900
June 30, 2025	406	94	70	₹30.1800
March 31, 2025	536	165	120	₹51.8900
Dec. 31, 2024	515	122	91	₹
Sept. 30, 2024	524	113	82	₹35.6920
June 30, 2024	464	92	103	₹29.6200
March 31, 2024	732	188	137	₹59.3100
Dec. 31, 2023	694	189	138	₹59.7900
Sept. 30, 2023	715	210	152	₹66.0800
June 30, 2023	706	183	123	₹53.3700

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	444	477	423	480	415	539	526	468	739	706	726	722	762
Operating revenue	438	472	420	475	406	536	524	464	732	694	715	706	736
Other income	6	4	3	5	9	3	2	5	6	12	12	16	26
Operating expenses	322	330	330	341	311	364	404	348	514	506	506	528	507
Operating profit	115	143	90	134	95	172	120	116	219	187	208	178	230
Operating profit margin	26.3%	30.2%	21.5%	28.2%	23.4%	32.1%	22.8%	25.0%	29.9%	27.0%	29.2%	25.2%	31.2%
Depreciation	9	9	10	9	9	10	9	9	10	10	10	10	10
Interest	0	0	1	0	0	0	0	0	0	0	0	1	0
Exceptional items, gain / (loss)	—	—	—	-27	—	—	—	-19	-27	—	—	—	18
Profit before tax	112	138	83	102	94	165	113	92	188	189	210	183	264
Tax	29	35	21	26	25	46	30	24	52	51	58	60	73
Net profit	84	103	62	76	70	120	82	—	137	138	152	123	190
EPS	36.26	44.55	26.79	32.99	30.18	51.89	35.69	29.62	59.31	59.79	66.08	53.37	82.67
Net profit (TTM)	324	310	327	347	—	—	—	—	549	603	596	575	573
EPS (TTM)	140.59	134.51	141.85	150.75	147.38	176.51	184.41	214.80	238.55	261.91	258.96	249.72	248.63

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Dec 25	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17	Dec 16
Total income (before exceptional items)	-13.2%	-9.1%	1,857^†	2,916^†	2,842^†	3,031^†	2,992^†	3,165^†	2,861^†	2,575^†	2,441^†
Operating revenue	-12.8%	-8.7%	1,837^†	2,851^†	2,770^†	2,957^†	2,902^†	3,071^†	2,772^†	2,491^†	2,369^†
Other income	—	—	20^†	65^†	72^†	74^†	90^†	94^†	90^†	83^†	72^†
Operating expenses	—	—	1,346^†	2,047^†	2,066^†	2,194^†	2,189^†	—	—	—	1,840^†
Operating profit	-11.3%	-7.2%	491^†	804^†	704^†	762^†	713^†	—	—	—	528^†
Operating profit margin	—	—	26.7%^†	28.2%^†	25.4%^†	25.8%^†	24.6%^†	—	—	—	22.3%^†
Depreciation	—	—	37^†	40^†	42^†	67^†	82^†	100^†	103^†	—	131^†
Interest	—	—	2^†	2^†	2^†	2^†	2^†	—	—	—	2^†
Exceptional items, gain / (loss)	—	—	-27^†	18^†	132^†	489^†	-42^†	-59^†	0^†	0^†	0^†
Profit before tax	-19.9%	-8.1%	445^†	846^†	864^†	1,258^†	677^†	600^†	610^†	515^†	466^†
Tax	—	—	118^†	243^†	244^†	313^†	200^†	186^†	229^†	189^†	169^†
Net profit	-19.3%	-7.3%	327^†	603^†	621^†	944^†	478^†	414^†	381^†	326^†	297^†
EPS	-19.3%	-7.3%	141.85^†	261.91^†	269.47^†	410.06^†	207.38^†	179.85^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Dec 25	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17	Dec 16
Operating margin	26.7%^†	28.2%^†	25.4%^†	25.8%^†	24.6%^†	—	—	—	22.3%^†
EBIT margin	24.3%^†	29.7%^†	31.3%^†	42.6%^†	23.4%^†	—	—	—	19.7%^†
PBT margin	24.2%^†	29.7%^†	31.2%^†	42.5%^†	23.3%^†	19.5%^†	22.0%^†	20.7%^†	19.7%^†
Net margin	17.8%^†	21.2%^†	22.4%^†	31.9%^†	16.5%^†	13.5%^†	13.7%^†	13.1%^†	12.5%^†
Interest coverage	262.59x^†	492.50x^†	509.41x^†	699.67x^†	377.22x^†	—	—	—	311.73x^†
Dividend payout	135.4%^†	74.1%^†	138.8%^†	30.5%^†	51.1%^†	36.7%^†	—	—	—
Earnings retention	-35.4%^†	25.9%^†	-38.8%^†	69.5%^†	48.9%^†	63.3%^†	—	—	—
Current ratio	1.88x	—	—	—	—	—	—	—	—
Quick ratio	1.24x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	—	—	—	—	—	—	—	—
Return on equity	43.6%^†	—	—	—	—	—	—	—	—
Return on assets	26.0%^†	—	—	—	—	—	—	—	—
Return on capital employed	58.5%^†	—	—	—	—	—	—	—	—
Asset turnover	1.46x^†	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
Dec. 31, 2025	438	-11	-448	26	413

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
Dec. 31, 2025	1,255	749	726	0	0	922	491	263	303	312

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.